Stay updated on Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.3, replacing the previous v3.6.2. This indicates a small platform update rather than a change to the study data displayed.
    Difference
    0.1%
    Check dated 2026-07-03T23:27:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Record History now shows Revision: v3.6.2, replacing Revision: v3.6.0. This reflects a minor platform update to the history-tracking interface rather than changes to study data.
    Difference
    0.1%
    Check dated 2026-06-26T20:38:17.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The record history now shows that participant recruitment has ended and the study documentation has a new revision (v3.6.0), with the prior revision (v3.5.5) removed.
    Difference
    0.4%
    Check dated 2026-06-12T13:34:18.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new page revision, v3.5.5, was added to the history and the previous revision, v3.5.4, was removed, reflecting an update to the record history.
    Difference
    0.1%
    Check dated 2026-06-05T09:18:54.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous v3.5.3 revision tag and signaling a maintenance update to the page template.
    Difference
    0.1%
    Check dated 2026-05-15T03:25:50.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The history now shows a newer revision tag, v3.5.3, in place of the previous v3.5.2 entry, indicating an update to the page record.
    Difference
    0.1%
    Check dated 2026-04-30T17:26:26.000Z thumbnail image

Stay in the know with updates to Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib±Fulvestrant in HER2+/ER+ Metastatic Breast Cancer Clinical Trial page.